Literature DB >> 26851752

The epidemic of oesophageal carcinoma: Where are we now?

Aaron P Thrift1.   

Abstract

Since the early 1970s, the incidence of oesophageal adenocarcinoma has increased dramatically in most Western populations. In contrast, the incidence of oesophageal squamous-cell carcinoma has decreased in these same populations. Epidemiological studies conducted over the past decade have provided great insights into the etiology of oesophageal cancer. These studies have identified gastro-oesophageal reflux disease, obesity and cigarette smoking as risk factors for oesophageal adenocarcinoma, while use of nonsteroidal anti-inflammatory drugs and infection with Helicobacter pylori are associated with reduced risk of oesophageal adenocarcinoma. For oesophageal squamous-cell carcinoma, alcohol and cigarette smoking are the two major risk factors underlying most cases. This review combines a synthesis of these studies with an analysis of data from the United States National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program to discuss the change in incidence of oesophageal cancer and summarize current knowledge of risk factors.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Barrett’s oesophagus; Epidemiology; Gastro-oesophageal reflux disease; Obesity; Oesophageal cancer

Mesh:

Year:  2016        PMID: 26851752     DOI: 10.1016/j.canep.2016.01.013

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  81 in total

1.  Novel Screening Alternatives for Barrett Esophagus.

Authors:  Apoorva Krishna Chandar; Anamay Sharma; Amitabh Chak
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-05

2.  No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Authors:  Jing Dong; Puya Gharahkhani; Wong-Ho Chow; Marilie D Gammon; Geoffrey Liu; Carlos Caldas; Anna H Wu; Weimin Ye; Lynn Onstad; Lesley A Anderson; Leslie Bernstein; Paul D Pharoah; Harvey A Risch; Douglas A Corley; Rebecca C Fitzgerald; Prasad G Iyer; Brian J Reid; Jesper Lagergren; Nicholas J Shaheen; Thomas L Vaughan; Stuart MacGregor; Sharon Love; Claire Palles; Ian Tomlinson; Ines Gockel; Andrea May; Christian Gerges; Mario Anders; Anne C Böhmer; Jessica Becker; Nicole Kreuser; Rene Thieme; Tania Noder; Marino Venerito; Lothar Veits; Thomas Schmidt; Claudia Schmidt; Jakob R Izbicki; Arnulf H Hölscher; Hauke Lang; Dietmar Lorenz; Brigitte Schumacher; Rupert Mayershofer; Yogesh Vashist; Katja Ott; Michael Vieth; Josef Weismüller; Markus M Nöthen; Susanne Moebus; Michael Knapp; Wilbert H M Peters; Horst Neuhaus; Thomas Rösch; Christian Ell; Janusz Jankowski; Johannes Schumacher; Rachel E Neale; David C Whiteman; Aaron P Thrift
Journal:  Clin Gastroenterol Hepatol       Date:  2019-02-01       Impact factor: 11.382

3.  Left thoracotomy for middle or lower thoracic esophageal carcinoma: still Sweet enough?

Authors:  Zhi-Qiang Wang; Wen-Ping Wang; Yong Yuan; Yang Hu; Jun Peng; Yun-Cang Wang; Long-Qi Chen
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 4.  Cellular Origins of Barrett's Esophagus: the Search Continues.

Authors:  Horace Rhee; David H Wang
Journal:  Curr Gastroenterol Rep       Date:  2018-09-26

5.  Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma.

Authors:  Christina Oetzmann von Sochaczewski; Thomas Haist; Michael Pauthner; Markus Mann; Susanne Braun; Christian Ell; Dietmar Lorenz
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

6.  Comparison of "Nil by Mouth" Versus Early Oral Intake in Three Different Diet Regimens Following Esophagectomy.

Authors:  Kristine Elisabeth Eberhard; Michael Patrick Achiam; Hans Christian Rolff; Mohamed Belmouhand; Lars Bo Svendsen; Morten Thorsteinsson
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

7.  Low Prevalence of Suspected Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease Without Alarm Symptoms.

Authors:  Emery C Lin; Jennifer Holub; David Lieberman; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-07       Impact factor: 11.382

8.  Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus.

Authors:  Alok K Shah; Gunter Hartel; Ian Brown; Clay Winterford; Renhua Na; Kim-Anh Lê Cao; Bradley A Spicer; Michelle A Dunstone; Wayne A Phillips; Reginald V Lord; Andrew P Barbour; David I Watson; Virendra Joshi; David C Whiteman; Michelle M Hill
Journal:  Mol Cell Proteomics       Date:  2018-08-10       Impact factor: 5.911

9.  Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.

Authors:  Mimi C Tan; Nabil Mansour; Donna L White; Amy Sisson; Hashem B El-Serag; Aaron P Thrift
Journal:  Aliment Pharmacol Ther       Date:  2020-05-26       Impact factor: 8.171

Review 10.  Accuracy of endoscopic ultrasound in esophageal cancer staging.

Authors:  Timothy Krill; Michelle Baliss; Russel Roark; Michael Sydor; Ronald Samuel; Jenine Zaibaq; Praveen Guturu; Sreeram Parupudi
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.